Global Gene Therapy Market Size & Trends Report Segmented by Type (Gene Silencing, Cell Replacement, Gene Augmentation), Vector (Viral, Non-viral), Therapeutic Area, Route of Administration (Intravenous), & Regional Forecasts to 2029

1. Introduction
   • Introduction
   • Market Scope
     • Market Definition
     • Segments Covered
     • Regional Segmentation
   • Research Timeframe
   • Currency Considered
   • Study Limitations
   • Stakeholders
   • List of Abbreviations
   • Key Conferences and Events (2023-2024)
2. Research Methodology
   • Secondary Research
   • Primary Research
   • Market Estimation
     • Bottom-Up Approach
     • Top-Down Approach
   • Market Forecasting
3. Executive Summary
   • Gene Therapy Market Snapshot (2023-2029)
   • Segment Overview
   • Regional Snapshot
   • Competitive Insights
4. Market ologies such as CRISPR-Cas9
5. Rising investment in R&D and clinical trials for novel therapies
6. Supportive regulatory frameworks and expedited approval pathways
7. Growing demand for personalized medicine
8. Restraints
   • High costs of gene therapy treatments
   • Safety concerns related to long-term effects and immune responses
   • Limited patient awareness and accessibility in developing regions
9. Opportunities
   • Expansion of gene therapy applications to treat common and rare diseases
   • Shift toward decentralized manufacturing to ensure faster production and accessibility
10. Key Market Trends
    • Adoption of CRISPR-Cas9 and other advanced gene-editing technologies
    • Utilization of AI and M/L to optimize therapy development and clinical trials
11. Unmet Market Needs
12. Industry Speaks
13. Regulatory Analysis
14. Global Gene Therapy Market Size & Forecast (2022-2029), By Type, USD Million
    • Introduction
    • Gene Silencing
    • Cell Replacement
    • Gene Augmentation
    • Other Therapies
15. Global Gene Therapy Market Size & Forecast (2022-2029), By Vector, USD Million
    • Introduction
    • Viral Vectors
    • Non-viral Vectors
16. Global Gene Therapy Market Size & Forecast (2022-2029), By Therapeutic Area, USD Million
    • Introduction
    • Neurology
    • Oncology
    • Hepatology
    • Other Therapeutic Areas
17. Global Gene Therapy Market Size & Forecast (2022-2029), By Route of Administration, USD Million
    • Introduction
    • Intravenous
    • Others
18. Global Gene Therapy Market Size & Forecast (2022-2029), By R
19. Introduction
20. North America Gene Therapy Market Size & Forecast (2022-2029), By Country, USD Million
    • US
      • Market Size & Forecast, By Type (USD Million)
      • Market Size & Forecast, By Vector (USD Million)
      • Market Size & Forecast, By Therapeutic Area (USD Million)
      • Market Size & Forecast, By Route of Administration (USD Million)
    • Canada
      • Market Size & Forecast, By Type (USD Million)
      • Market Size & Forecast, By Vector (USD Million)
      • Market Size & Forecast, By Therapeutic Area (USD Million)
      • Market Size & Forecast, By Route of Administration (USD Million)
21. Europe Gene Therapy Market Size & Forecast (2022-2029), By Country, USD Million
    • UK
      • Market Size & Forecast, By Type (USD Million)
      • Market Size & Forecast, By Vector (USD Million)
      • Market Size & Forecast, By Therapeutic Area (USD Million)
      • Market Size & Forecast, By Route of Administration (USD Million)
    • Germany
      • Market Size & Forecast, By Type (USD Million)
      • Market Size & Forecast, By Vector (USD Million)
      • Market Size & Forecast, By Therapeutic Area (USD Million)
      • Market Size & Forecast, By Route of Administration (USD Million)
    • France
      • Market Size & Forecast, By Type (USD Million)
      • Market Size & Forecast, By Vector (USD Million)
      • Market Size & Forecast, By Therapeutic Area (USD Million)
      • Market Size & Forecast, By Route of Administration (USD Million)
    • Italy
      • Market Size & Forecast, By Type (USD Million)
      • Market Size & Forecast, By Vector (USD Million)
      • Market Size & Forecast, By Therapeutic Area (USD Million)
      • Market Size & Forecast, By Route of Administration (USD Milliot Size & Forecast, By Type (USD Million)
      • Market Size & Forecast, By Vector (USD Million)
      • Market Size & Forecast, By Therapeutic Area (USD Million)
      • Market Size & Forecast, By Route of Administration (USD Million)
    • Rest of Europe
      • Market Size & Forecast, By Type (USD Million)
      • Market Size & Forecast, By Vector (USD Million)
      • Market Size & Forecast, By Therapeutic Area (USD Million)
      • Market Size & Forecast, By Route of Administration (USD Million)
22. Asia Pacific (APAC) Gene Therapy Market Size & Forecast (2022-2029), By Country, USD Million
    • China
      • Market Size & Forecast, By Type (USD Million)
      • Market Size & Forecast, By Vector (USD Million)
      • Market Size & Forecast, By Therapeutic Area (USD Million)
      • Market Size & Forecast, By Route of Administration (USD Million)oet Size & Forecast, By Type (USD Million)
      • Market Size & Forecast, By Vector (USD Million)
      • Market Size & Forecast, By Therapeutic Area (USD Million)
      • Market Size & Forecast, By Route of Administration (USD Million)
    • India
      • Market Size & Forecast, By Type (USD Million)
      • Market Size & Forecast, By Vector (USD Million)
      • Market Size & Forecast, By Therapeutic Area (USD Million)
      • Market Size & Forecast, By Route of Administration (USD Million)
    • Rest of Asia Pacific
      • Market Size & Forecast, By Type (USD Million)
      • Market Size & Forecast, By Vector (USD Million)
      • Market Size & Forecast, By Therapeutic Area (USD Million)
      • Market Size & Forecast, By Route of Administration (USD Million)
23. Latin America (LATAM) Gene Therapy Market Size & Forecast (2022-2029), USD Mist, By Type (USD Million)
24. Market Size & Forecast, By Vector (USD Million)
25. Market Size & Forecast, By Therapeutic Area (USD Million)
26. Market Size & Forecast, By Route of Administration (USD Million)
27. Middle East & Africa (MEA) Gene Therapy Market Size & Forecast (2022-2029), USD Million
    • Market Size & Forecast, By Type (USD Million)
    • Market Size & Forecast, By Vector (USD Million)
    • Market Size & Forecast, By Therapeutic Area (USD Million)
    • Market Size & Forecast, By Route of Administration (USD Million)
28. Competitive Landscape
    • Key Players and their Competitive Positioning
      • Key Player Comparison
      • Segment-wise Player Mapping
      • Market Share Analysis (2023)
      • Company Categorization Matrix
        • Dominants/Leaders
        • New Entrants
        • Emerging Players
        • Innovative Players
      • Key Strategies Assessment, By Player (2022-2024)
        • New Product Launches
        • Partnerships, Agreements, & Collaborations
        • Mergers & Acquisitions
        • Geographic Expansion

11. Company Profiles*

(Business Overview, Financial Performance**, Products Offered, Recent Developments)

• Amgen Inc.
• Novartis AG
• Hoffmann-La Roche
• Gilead Sciences, Inc.
• bluebird bio, Inc.
• Bristol-Myers Squibb Company
• Legend Biotech
• BioMarin
• uniQure N.V.
• Sarepta Therapeutics, Inc.
• Other Prominent Players